Immunology patent intelligence

US 7910299

Methods for diagnosing systemic lupus erythematosus

Regents of the University of Minnesota · Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7811996

Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection

The Regents of the University of California · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7812029

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7666411

Methods of treating and preventing colitis involving IL-13 and NK-T cells

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7662573

Methods for evaluating osteoarthritis risk

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7659280

2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7582648

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

Rigel Pharmaceuticals, Inc. · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7575742

Method of treating autoimmune diseases with interferon-beta and IL-2R antagonist

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7560466

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7517886

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

Rigel Pharmaceuticals, Inc. · Granted Tue Apr 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7452879

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

Rigel Pharmaceuticals, Inc. · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7399465

Pharmaceutical compositions for treating arthritis and inflammatory disease

The Regents of the University of California · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7361350

Use of an IL-1 antagonist for treating arthritis

REGENERON PHARMACEUTICALS, INC. · Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7294687

Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7273613

Diagnostics and therapy of Epstein-Barr virus in autoimmune disorders

The Board of Regents of the University of Oklahoma · Granted Tue Sep 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7183065

Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens

The Regents of the University of California · Granted Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7141553

A3AR agonists for the treatment of inflammatory arthritis

Can-Fite Biopharma Ltd. Israel · Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7138237

Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen

The Regents of the University of California · Granted Tue Nov 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7122542

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7118865

Methods for diagnosing severe systemic lupus erythematosus

Regents of the University of Minnesota · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7094404

Method for treating malignancy and autoimmune disorders in humans using tac antibodies

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7094597

Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis

The Regents of the University of California · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6946132

Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis

The Regents of the University of California · Granted Tue Sep 20 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6936599

Estriol therapy for multiple sclerosis and other autoimmune diseases

The Regents of the University of California · Granted Tue Aug 30 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6930084

Treating arthritis with TNF receptor releasing enzyme

The Regents of the University of California · Granted Tue Aug 16 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6821739

Methods of diagnosing and treating Crohn's disease using Pseudomonas antigens

The Regents of the University of California · Granted Tue Nov 23 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6809077

Cyclosporin analogs for the treatment of autoimmune diseases

Enanta Pharmaceuticals, Inc. · Granted Tue Oct 26 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6685941

Methods of treating autoimmune disease via CTLA-4Ig

United States of America as represented by the Secretary of the Air Force · Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6537768

Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC panca antigens

The Regents of the University of California · Granted Tue Mar 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6521615

Diagnosing an animal for pyrophosphate gout, osteoporosis, or osteoarthritis by assaying intracellular pyrophosphate content in peripheral blood cells

The Regents of the University of California · Granted Tue Feb 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6518259

Compositions for treating autoimmune disease

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6479465

Methods of treating colitis using STAT-4 anti-sense oligonucleotides

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 12 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6468537

Localization of major peptide autoepitopes for nucleosome specific T cells of systemic lupus erythematosus

The Board of Trustees of Northwestern University · Granted Tue Oct 22 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6410824

Animal model for psoriasis for the prevention and treatment of psoriasis in humans

Protein Design Labs, Inc. · Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6365616

Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 02 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6232444

Conserved anti-DNA antibody idiotype associated with nephritis in murine and human lupus

The Regents of the University of California · Granted Tue May 15 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6162787

Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions

Immudyne, Inc. · Granted Tue Dec 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6153200

Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis

The Regents of the University of California · Granted Tue Nov 28 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6098631

Compositions and methods for treating autoimmune disease

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 08 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6083503

Interleukin-2 stimulated T lymphocyte cell death for the treatment of autoimmune diseases, allergic responses, and graft rejection

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6033864

Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens

The Regents of the University of California · Granted Tue Mar 07 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)